GO
Loading...

Medtronic Inc

More

  • Final Glance: Medical Devices companies Thursday, 24 Jul 2014 | 6:22 PM ET

    Allergan fell $1.86 or 1.1 percent, to $170.57. Baxter International Inc. rose$. 16 or. 2 percent, to $77.00. Boston Scientific Corp. rose$. 24 or 1.8 percent, to $13.26.

  • At least eight European law firms are pitching their services to major U.S. law firms and Wall Street banks, hoping that U.S. companies considering an inversion choose Ireland, Britain or the Netherlands for their new tax domicile, according to people with knowledge of the matter.

  • Midday Glance: Medical Devices companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Allergan fell$. 78 or. 5 percent, to $171.65. Baxter International Inc. rose$. 20 or. 3 percent, to $77.04. Boston Scientific Corp. rose$. 09 or. 7 percent, to $13.11.

  • Early Glance: Medical Devices companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Allergan fell $1.51 or. 9 percent, to $170.92. Baxter International Inc. fell$. 13 or. 2 percent, to $76.71. Boston Scientific Corp. rose$. 02 or. 2 percent, to $13.04.

  • Final Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Allergan fell$. 71 or. 4 percent, to $170.43. Boston Scientific Corp. rose$. 30 or 2.4 percent, to $12.85. Medtronic rose$. 30 or. 5 percent, to $62.71.

  • Early Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 11:16 AM ET

    Allergan rose $1.04 or. 6 percent, to $172.18. Baxter International Inc. rose$. 55 or. 7 percent, to $76.66. Boston Scientific Corp. rose$. 23 or 1.8 percent, to $12.78.

  • Midday Glance: Medical Devices companies Friday, 18 Jul 2014 | 1:19 PM ET

    Allergan rose $1.25 or. 8 percent, to $167.07. Baxter International Inc. fell$. 25 or. 3 percent, to $76.00. Boston Scientific Corp. rose$. 18 or 1.4 percent, to $12.64.

  • Glance: Biggest corporate deals so far this year Friday, 18 Jul 2014 | 11:57 AM ET

    Abbvie Inc.' s deal to combine with Shire PLC would be the largest made so far this year, excluding assumed debt.

  • AbbVie, Shire agree on $55B combination Friday, 18 Jul 2014 | 6:43 AM ET

    The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home. But the new company will be controlled by shareholders of North Chicago, Illinois- based AbbVie, who will own about 75 percent of the new company's stock.

  • July 17- U.S. orthopedics company Stryker Corp on Thursday reported slightly higher second-quarter profit that was in line with Wall Street expectations and said it was always in the market for deals. In the most recent such deal in the medical device sector, Medtronic Inc last month agreed to buy Covidien for $43 billion.

  • UPDATE 2-St. Jude not keen to join inversion deal craze Wednesday, 16 Jul 2014 | 3:39 PM ET

    In the most recent such deal in the medical device sector, Medtronic Inc last month agreed to buy Covidien for $43 billion. The move will allow Medtronic to re-domicile to Ireland to take advantage of low corporate tax rates and to access cash overseas without having to pay high repatriation costs.

  • Midday Glance: Medical Devices companies Wednesday, 16 Jul 2014 | 2:54 PM ET

    Allergan rose$. 59 or. 4 percent, to $164.97. Baxter International Inc. fell$. 23 or. 3 percent, to $76.53. Boston Scientific Corp. rose$. 09 or. 7 percent, to $12.94.

  • Treasury Secretary Jacob Lew urged Congress on Wednesday to take steps quickly to discourage U.S. companies from moving their tax domiciles abroad to avoid federal taxes. "Congress should enact legislation immediately," Lew told a business conference in New York hosted by cable television channel CNBC.

  • Early Glance: Medical Devices companies Wednesday, 16 Jul 2014 | 11:11 AM ET

    Allergan rose$. 09 or. 1 percent, to $164.47. Baxter International Inc. fell$. 09 or. 1 percent, to $76.67. Boston Scientific Corp. rose$. 07 or. 5 percent, to $12.92.

  • US companies look overseas for tax bill relief Monday, 14 Jul 2014 | 3:05 PM ET

    Generic drugmaker Mylan Inc. said Monday it will become part of a new company organized in the Netherlands in a $5.3 billion deal to acquire some of Abbott Laboratories' generic-drugs business.

  • Midday Glance: Medical Devices companies Monday, 14 Jul 2014 | 1:29 PM ET

    Allergan fell$. 34 or. 2 percent, to $166.09. Baxter International Inc. rose$. 03 or percent, to $76.62. Boston Scientific Corp. fell$. 13 or. 9 percent, to $13.17.

  • Early Glance: Medical Devices companies Monday, 14 Jul 2014 | 10:47 AM ET

    Allergan fell$. 82 or. 5 percent, to $165.61. Baxter International Inc. rose$. 20 or. 3 percent, to $76.79. Boston Scientific Corp. fell$. 10 or. 8 percent, to $13.19.

  • FACTBOX-M&A frenzy transforming global pharma Monday, 14 Jul 2014 | 9:27 AM ET

    July 14- Several multi-billion dollar deals and bids have made 2014 a busy year for healthcare acquisitions, despite Pfizer pulling its $118 billion offer for AstraZeneca.

  • Midday Glance: Medical Devices companies Friday, 11 Jul 2014 | 1:37 PM ET

    Allergan rose$. 08 or percent, to $165.68. Baxter International Inc. fell$. 54 or. 7 percent, to $76.21. Boston Scientific Corp. fell$. 07 or. 5 percent, to $13.03.

  • Early Glance: Medical Devices companies Friday, 11 Jul 2014 | 10:30 AM ET

    Allergan fell$. 62 or. 4 percent, to $164.98. Baxter International Inc. fell$. 54 or. 7 percent, to $76.21. Boston Scientific Corp. fell$. 15 or 1.1 percent, to $12.95.